thereportsworld

  Gastrointestinal drugs Market Overview Growing incidence of GI diseases owing to rising risk factors is expected to drive a significant demand. According to World Gastroenterology Organization, 35 to 40 % of world’s population suffers from acute or chronic GI complication. The situation has been complicated by a rise in risk factors such as a change in dietary pattern, stress, infections especially by Helicobacter pylori, cancer, intake of fatty and spicy foods and others. Thus, a large and growing market is easily comprehensible. Drug development and rising awareness are expected to drive a substantial growth. The development of highly efficacious and effective drugs such as the proton pump inhibitors (PPIs) with pronounced and long-lasting action and fewer to no side effects are driving the market. PPIs have superseded the other class of medications such as the H2-receptor antagonists and are among the most widely sold drugs globally. Side effects associated with the drugs ...

  Gastrointestinal drugs Market Overview Growing incidence of GI diseases owing to rising risk factors is expected to drive a significant demand. According to World Gastroenterology Organization, 35 to 40 % of world’s population suffers from acute or chronic GI complication. The situation has been complicated by a rise in risk factors such as a change in dietary pattern, stress, infections especially by Helicobacter pylori, cancer, intake of fatty and spicy foods and others. Thus, a large and growing market is easily comprehensible. Drug development and rising awareness are expected to drive a substantial growth. The development of highly efficacious and effective drugs such as the proton pump inhibitors (PPIs) with pronounced and long-lasting action and fewer to no side effects are driving the market. PPIs have superseded the other class of medications such as the H2-receptor antagonists and are among the most widely sold drugs globally. Side effects associated wi...